JP2008023520A - 飲料水の製造方法及び装置 - Google Patents
飲料水の製造方法及び装置 Download PDFInfo
- Publication number
- JP2008023520A JP2008023520A JP2007143907A JP2007143907A JP2008023520A JP 2008023520 A JP2008023520 A JP 2008023520A JP 2007143907 A JP2007143907 A JP 2007143907A JP 2007143907 A JP2007143907 A JP 2007143907A JP 2008023520 A JP2008023520 A JP 2008023520A
- Authority
- JP
- Japan
- Prior art keywords
- water
- reverse osmosis
- drinking
- powder
- osmosis membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000020188 drinking water Nutrition 0.000 title claims abstract description 35
- 239000003651 drinking water Substances 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 86
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 39
- 239000011707 mineral Substances 0.000 claims abstract description 39
- 239000000919 ceramic Substances 0.000 claims abstract description 28
- 238000001223 reverse osmosis Methods 0.000 claims abstract description 23
- 239000012528 membrane Substances 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 8
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 239000008400 supply water Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 31
- 239000008280 blood Substances 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 21
- 239000011435 rock Substances 0.000 abstract description 9
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000035622 drinking Effects 0.000 description 31
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 22
- 239000008103 glucose Substances 0.000 description 22
- 239000008399 tap water Substances 0.000 description 15
- 235000020679 tap water Nutrition 0.000 description 15
- 230000008859 change Effects 0.000 description 12
- 230000005855 radiation Effects 0.000 description 12
- 230000009471 action Effects 0.000 description 11
- 150000002500 ions Chemical class 0.000 description 11
- 230000037396 body weight Effects 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 238000001179 sorption measurement Methods 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 239000000395 magnesium oxide Substances 0.000 description 5
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 5
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 5
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 5
- 229910001950 potassium oxide Inorganic materials 0.000 description 5
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 5
- 229910001948 sodium oxide Inorganic materials 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 3
- 239000000292 calcium oxide Substances 0.000 description 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- TXKMVPPZCYKFAC-UHFFFAOYSA-N disulfur monoxide Inorganic materials O=S=S TXKMVPPZCYKFAC-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- SIWVEOZUMHYXCS-UHFFFAOYSA-N oxo(oxoyttriooxy)yttrium Chemical compound O=[Y]O[Y]=O SIWVEOZUMHYXCS-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical compound S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- ZCUFMDLYAMJYST-UHFFFAOYSA-N thorium dioxide Chemical compound O=[Th]=O ZCUFMDLYAMJYST-UHFFFAOYSA-N 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Landscapes
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
【解決手段】逆浸透膜を通過した水をヒューミックシェール(古代植物由来の堆積岩)の粉末を含むセラミックス焼結体に接触させる。好ましくは、逆浸透膜を通過した水を、ヒューミックシェールの粉末を含むセラミックス焼結体、遠赤外線放射物質を含むセラミックス焼結体及びマイナスイオン放射物質を含むセラミックス焼結体に接触させる。ヒューミックシェールの粉末として、これに含まれる植物由来のミネラルの一部を冷水に溶出した後の残渣の粉末を用いることができる。
【選択図】 図1
Description
二酸化ケイ素 44.30
酸化アルミニウム 30.38
五酸化リン 9.57
酸化第二鉄 6.36
二酸化トリウム 3.13
酸化イットリウム 1.44
酸化ナトリウム 1.28
酸化ジルコニウム 1.16
酸化カリウム 0.86
酸化マグネシウム 0.60
酸化スズ 0.30
強熱減量 0.62
強熱減量とは、上記成分を焼結するときに失われる重量である。
二酸化ケイ素 53.00
酸化アルミニウム 34.00
酸化第二鉄 5.80
三酸化二ホウ素 2.60
酸化マグネシウム 1.72
酸化ナトリウム 1.40
酸化マンガン 0.40
酸化力ルシウム 0.24
酸化チタン 0.20
酸化亜鉛 0.14
酸化カリウム 0.10
リチウム 0.04
強熱減量 0.36
二酸化ケイ素 38.19
酸化アルミニウム 17.70
酸化第二鉄 19.54
酸化マンガン 11.26
酸化コバルト 5.42
酸化カルシウム 2.81
酸化マグネシウム 1.41
酸化クロム 1.36
酸化ナトリウム 1.25
酸化カリウム 0.94
強熱減量 0.12
堆積岩粉末 60
粘土 30
ガラス質材料 10
炭素 31
ケイ素 12.5
鉄 4.316
カルシウム 0.327
マグネシウム 0.369
銅 0.181
ナトリウム 0.0277
セレン 0.0133
マンガン 0.0123
リン 0.0051
チタニウム 0.00439
亜鉛 0.00437
ヨウ素 0.00143
ニッケル 0.000527
クロム 0.000498
コバルト 0.000383
ゲルマニウム 0.000169
カリウム 0.000124
バナジウム 0.000106
モリブデン 0.000071
金 0.00001以下
その他 53種類
酸化ケイ素 48.80
酸化アルミニウム 35.08
酸化鉄 1.15
酸化チタン 0.59
酸化カルシウム 0.19
酸化マグネシウム 0.14
酸化カリウム 0.90
酸化ナトリウム 0.07
強熱減量 13.08
酸化ケイ素 66.7
酸化アルミニウム 8.26
酸化鉄 0.71
酸化チタン 0.78
酸化カルシウム 8.17
酸化マグネシウム 3.34
酸化カリウム 0.54
酸化ナトリウム 10.6
酸化マンガン 0.01
酸化銅 0.02
酸化硫黄 0.17
強熱減量 0.7
処理水飲用群、水道水飲用群共に、経過日数に比例して体重が増加することが認められた。特に処理水飲用群については水道水飲用群よりも体重増加が著しい。このことから、処理水には毒性のないことが分かる。
放射線の照射によって処理水飲用群、水道水飲用群共に、体重の減少が観測された。しかし、処理水飲用群については、その経過は水道水飲用群より抑制されている。このことから、処理水の飲用により放射防護機能が向上している可能性がある。
処理水飲用群では血糖値低下が観測され、処理水の飲用により血糖値上昇が抑制されることが認められる。処理水の飲用が体重変化に影響がないことから、この血糖値の低下はインシュリン非依存性の2型糖尿病に有効であることが予測される。
処理水飲用群、水道水飲用群ともに、放射線照射後の血糖値は減少を示す。放射線の影響によって非照射群ほど処理水飲用の効果は顕著ではないが、水道水飲用群と比較すると血糖値の低下が大きく、放射線の作用があっても血糖値の抑制効果が示されている。このことは、高血糖値の放射線治療患者に対しても処理水の飲用による血糖値抑制効果が発揮されると考えられる。
7 セラミックス充填フィルター
8 接続管
11 給水口
12 吐出口
Claims (4)
- 逆浸透膜を通過した水をヒューミックシェールの粉末を含むセラミックス焼結体に接触させることを特徴とする、飲料水の製造方法。
- 逆浸透膜を通過した水を、ヒューミックシェールの粉末を含むセラミックス焼結体、遠赤外線放射物質を含むセラミックス焼結体及びマイナスイオン放射物質を含むセラミックス焼結体に接触させることを特徴とする、飲料水の製造方法。
- ヒューミックシェールの粉末がこれに含まれる植物由来のミネラルの一部を冷水に溶出した後のヒューミックシェールを粉砕して得られた粉末である、請求項1又は2記載の飲料水の製造方法。
- 逆浸透法により流入水を濾過する逆浸透膜フィルター(4)と、ヒューミックシェールの粉末を含むセラミックス焼結体を充填したセラミックス充填フィルター(7)と、逆浸透膜フィルター(4)に水を供給する給水口(11)と、逆浸透膜フィルター(4)を通過した水を上記セラミックス充填フィルター(7)に導く接続管(8)と、セラミックス充填フィルター(7)を通過した水を吐出する吐出口(12)とを備えている、飲料水の製造装置。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007143907A JP4040077B1 (ja) | 2006-06-20 | 2007-05-30 | 飲料水の製造方法及び装置 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006170393 | 2006-06-20 | ||
JP2007143907A JP4040077B1 (ja) | 2006-06-20 | 2007-05-30 | 飲料水の製造方法及び装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP4040077B1 JP4040077B1 (ja) | 2008-01-30 |
JP2008023520A true JP2008023520A (ja) | 2008-02-07 |
Family
ID=39078323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007143907A Expired - Fee Related JP4040077B1 (ja) | 2006-06-20 | 2007-05-30 | 飲料水の製造方法及び装置 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4040077B1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008255237A (ja) * | 2007-04-05 | 2008-10-23 | Geneses:Kk | 土壌改良材 |
WO2010135991A1 (zh) * | 2009-05-26 | 2010-12-02 | Jiang Sheng | 一种分子共振(mrm)水处理设备 |
GB2488630A (en) * | 2011-03-03 | 2012-09-05 | Graham Colin Brebner | A medium for treating water |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6120342B1 (ja) * | 2016-03-08 | 2017-04-26 | 株式会社スタイルアンドバリュージャパン | 美容組成物 |
-
2007
- 2007-05-30 JP JP2007143907A patent/JP4040077B1/ja not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008255237A (ja) * | 2007-04-05 | 2008-10-23 | Geneses:Kk | 土壌改良材 |
WO2010135991A1 (zh) * | 2009-05-26 | 2010-12-02 | Jiang Sheng | 一种分子共振(mrm)水处理设备 |
GB2488630A (en) * | 2011-03-03 | 2012-09-05 | Graham Colin Brebner | A medium for treating water |
Also Published As
Publication number | Publication date |
---|---|
JP4040077B1 (ja) | 2008-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103687816B (zh) | 具有功能性的氢水制造装置 | |
CN101574166B (zh) | 一种含有海洋深层水的具有保健功能的饮用水 | |
JP4040077B1 (ja) | 飲料水の製造方法及び装置 | |
JP5966073B2 (ja) | 紅参サポニン抽出物の製造方法 | |
EP2580168B1 (en) | Method for removal of radionuclides from ferrous ground water | |
CN203754525U (zh) | 一种全自动反冲洗式制水设备 | |
JP6328403B2 (ja) | 機能性水製造装置及び機能性水製造方法 | |
CN1166577C (zh) | 一种矿泉水的制备方法 | |
WO2008075992A1 (en) | Apparatus for continuous flux producing of silver ion water | |
CN201128707Y (zh) | 城乡超能净水加热一体机 | |
CN1207221C (zh) | 微量元素饮用水及其制造方法 | |
CN202912792U (zh) | 水处理设备 | |
CN101428893B (zh) | 麦饭石饮用水的制备方法 | |
KR20010079473A (ko) | 식품 및 의약품의 용도로서, 수많은 종류의 콜로이드성미량미네랄이 함유된 벤토나이트(또는 몬모릴로나이트) | |
CN108947057A (zh) | 一种硫酸钙镁型温泉水直饮水处理系统 | |
CN1827539A (zh) | 一种养生活性水的制造方法及设备 | |
CN108793485A (zh) | 一种可同时制备纯净水和含硒矿物质水的多功能净水器 | |
CN1840485A (zh) | 一种制备高能态生命动力水的净水机 | |
CN201923918U (zh) | 超滤膜及紫外线联用净水器 | |
CN1485283A (zh) | 麦饭石矿化水的制造方法 | |
CN203582624U (zh) | 一种全自动智能雨水净化系统 | |
CN1225339A (zh) | 纯净水生产中pH值的改善方法 | |
CN1660708A (zh) | 新生饮用水制备方法 | |
CN106977026A (zh) | 治疗癌症糖尿病帕金森氏症肝癌负氢水制造设备 | |
KR102225048B1 (ko) | 규소미네랄을 함유하는 기능성 음용수의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20071030 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20071106 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101116 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4040077 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111116 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111116 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121116 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131116 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |